SAN MATEO, Calif., July 7, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics company, today announced a multi-year relationship with AstraZeneca, a global biopharmaceutical company. Under this agreement AstraZeneca will gain access to Helix's continuously growing, deeply...
Hence then, the article about helix announces multi year agreement with astrazeneca to support genomic research for drug discovery and development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Helix Announces Multi-Year Agreement with AstraZeneca to Support Genomic Research for Drug Discovery and Development )
Also on site :
- Man Notices Small Lump on Knee, Then Faces Life-Saving Decision
- US budget slashing risks losing global scientific edge to China
- Jilly Cooper Audible Original ‘A Pressing Engagement’ To Star Rhea Norwood, Corey Mylchreest, Hannah Waddingham, Richard Ayoade, Vivian Oparah & Bessie Carter